Budesonide MMX in the Treatment of Ulcerative Colitis: Current Perspectives on Efficacy and Safety
Giovanni Maconi, Deborah Camatta, Rosanna Cannatelli, Francesca Ferretti, Anna Carvalhas Gabrielli, Sandro Ardizzone Gastroenterology Unit, Department of Biomedical and Clinical Sciences FBF – L.Sacco, University Hospital, Milan, ItalyCorrespondence: Giovanni MaconiGastroenterology Unit, D...
Saved in:
Main Authors: | Maconi G (Author), Camatta D (Author), Cannatelli R (Author), Ferretti F (Author), Carvalhas Gabrielli A (Author), Ardizzone S (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX® mesalamine
by: Nanda K, et al.
Published: (2012) -
Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX® mesalamine. [Corrigendum]
by: Nanda K, et al.
Published: (2013) -
Ultrasonographic Evaluation of Intestinal Fibrosis and Inflammation in Crohn's Disease. The State of the Art
by: Francesca Ferretti, et al.
Published: (2021) -
Preparation and characterization of pH-sensitive nanoparticles of budesonide for the treatment of ulcerative colitis
by: Zhou H, et al.
Published: (2018) -
Efficacy, safety, and predictors of response to infliximab therapy for ulcerative colitis
by: Mohamed G Fawaz, et al.
Published: (2022)